Single-use Bioprocessing Probes and Sensors Market Size - By Sensor Type (pH Sensors, Oxygen Sensors, Pressure Sensors, Conductivity Sensors, Flow Meters & Sensors), Workflow (Upstream, Downstream), End-use & Forecast, 2024 – 2032

Single-use Bioprocessing Probes and Sensors Market Size

Single-use Bioprocessing Probes and Sensors Market size was valued at USD 3.1 billion in 2023 and is estimated to grow at 13.7% CAGR from 2024 to 2032. Single-use bioprocessing probes and sensors are disposable components used in biopharmaceutical manufacturing processes. These probes and sensors are designed to monitor and control various parameters such as pH, temperature, dissolved oxygen, conductivity, and biomass in bioreactors and other bioprocessing equipment.
 

The global demand for biopharmaceuticals has been steadily rising due to factors such as an aging population, increasing prevalence of chronic diseases, and advancements in healthcare infrastructure. Biopharmaceuticals, including monoclonal antibodies, vaccines, and cell therapies, require precise and efficient bioprocessing technologies for manufacturing. Single-use bioprocessing probes and sensors play a crucial role in ensuring the quality, safety, and efficiency of biopharmaceutical production, thus experiencing increased demand alongside the growth of the biopharmaceutical industry.
 

Further, the biopharmaceutical industry is embracing single-use technologies due to their flexibility, speed, and reduced contamination risk compared to traditional stainless-steel equipment. These systems require less cleaning and validation, stimulating a trend towards their adoption, including single-use probes and sensors, to streamline manufacturing and expedite product launches.
 

Single-use Bioprocessing Probes and Sensors Market Trends

Continuous innovation in bioprocessing technology has led to the development of advanced bioreactor systems such as single-use bioreactors and downstream processing techniques. These advancements often incorporate single-use technologies to improve operational efficiency, reduce contamination risks, and enhance flexibility in manufacturing processes. Single-use bioprocessing probes and sensors are integral components of these advanced bioprocessing systems, driving their adoption in the industry.
 

• Regulatory authorities such as the FDA and EMA impose stringent guidelines and quality standards on biopharmaceutical manufacturing to ensure product safety, efficacy, and consistency.
   
• Single-use bioprocessing probes and sensors, when properly validated and qualified, can help biopharmaceutical manufacturers comply with these regulations by providing accurate and reliable monitoring and control of critical process parameters.
   
• Thus, as regulatory scrutiny increases, the demand for compliant single-use solutions is expected to rise, driving further growth in the market.
   

Single-use Bioprocessing Probes and Sensors Market Analysis

Based on sensor type, the single-use bioprocessing probes and sensors market is divided into pH sensors, oxygen sensors, pressure sensors, temperature sensors, conductivity sensors, flow meters & sensors, and other sensor types. The pH sensors segment of the market is forecasted to reach USD 2.2 billion by 2032, showcasing robust growth propelled by several key factors.
 

• pH monitoring is a critical parameter in bioprocessing operations, especially in industries such as biopharmaceuticals, food and beverages, and biotechnology. pH levels directly impact the efficacy and yield of bioprocesses, influencing cell growth, product quality, and overall process efficiency.
   
• Therefore, as bioprocessing continues to expand and evolve, the demand for accurate and reliable pH sensing technologies escalates accordingly.

Based on workflow, the single-use bioprocessing probes and sensors market is bifurcated into upstream, and downstream. The upstream segment accounted for USD 2.4 billion in 2023.
 

• Upstream bioprocessing serves as the cornerstone of biomanufacturing, initiating the cultivation of cells or microorganisms and profoundly shaping the quality and quantity of the final biologic product. This phase necessitates precise monitoring and control of critical parameters such as pH, temperature, dissolved oxygen, and agitation speed to optimize cell growth and productivity.
   
• Moreover, the biopharmaceutical industry is undergoing a notable expansion, driven by factors such as the rising incidence of chronic diseases, advancements in biotechnology, and the burgeoning demand for personalized medicine.
   
• This growth trajectory underscores an increased reliance on bioprocessing for the production of therapeutic proteins, antibodies, vaccines, and other biologics.
   
• Therefore, there's a surge in demand for single-use probes and sensors, which offer scalability, flexibility, and efficiency, thus aligning with the industry's evolving needs.
   

Based on end-use, the single-use bioprocessing probes and sensors market is bifurcated into academic and research institutes, biopharma & pharmaceutical manufacturers, and contract manufacturing organizations (CMOs) & contract development and manufacturing organizations (CDMOs). The academic and research institutes segment accounted for USD 1.4 billion in 2023.
 

• Academic and research institutes play a crucial role in advancing bioprocessing technologies through cutting-edge research and development activities. These institutions often receive funding from government grants, private organizations, and collaborations with industry players, enabling them to invest in state-of-the-art bioprocessing equipment, including probes and sensors.
   
• Moreover, as part of their educational curriculum, students and researchers engage in hands-on experiments and projects that require the use of bioprocessing probes and sensors. This demand stimulates the procurement of such equipment by academic and research institutions, contributing to market growth.

The single-use bioprocessing probes and sensors market in North America accounted for a significant revenue of 1.3 billion in 2023, and this trajectory is set to continue upwards.
 

• The increasing demand for biopharmaceuticals and biologics in the region is fueling the expansion of bioprocessing facilities, thereby creating a greater need for efficient and reliable single-use technologies such as probes and sensors.
   

The single-use bioprocessing probes and sensors industry in Germany is expected to experience significant and promising growth from 2024 to 2032.
 

• Germany has a robust biopharmaceutical industry with a strong emphasis on research and development. The increasing investment in biotechnology and biopharmaceutical manufacturing facilities is expected to fuel the demand for single-use bioprocessing technologies, including probes and sensors, during the forecast period.
   

UK is anticipated to witness robust growth in the global single-use bioprocessing probes and sensors market.
 

• The UK government and regulatory bodies prioritize the life sciences industry and provide support for research, development, and commercialization activities. Favorable regulatory frameworks and incentives encourage companies to invest in the development and deployment of single-use bioprocessing probes and sensors, accelerating market growth.
   

Japan single-use bioprocessing probes and sensors industry is anticipated to witness lucrative growth between 2024 – 2032.
 

• Collaboration between biopharmaceutical companies and technology providers for the development and commercialization of innovative single-use bioprocessing solutions is expected to further fuel market growth.
   
• These collaborations enable the exchange of expertise and resources, leading to the introduction of advanced probes and sensors tailored to meet the specific needs of biopharmaceutical manufacturers in Japan.
   

The single-use bioprocessing probes and sensors market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.
 

• Saudi Arabia has been actively investing in its biopharmaceutical industry, driven by rising healthcare demands and a growing population. With a shift towards biologics and biosimilars, there's a heightened need for efficient bioprocessing technologies, including single-use probes and sensors.
   

Single-use Bioprocessing Probes and Sensors Market Share

The single-use bioprocessing probes and sensors sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command significant influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.
 

Single-use Bioprocessing Probes and Sensors Market Companies

Some of the eminent market participants operating in the single-use bioprocessing probes and sensors industry include:

• Broadley-James Corporation
• Danaher Corporation
• Dover Corporation
• Eppendorf SE
• Emerson Electric Co.
• Hamilton Company
• Parker-Hannifin Corporation
• PreSens Precision Sensing GmbH
• Sartorius AG
• Stobbe Pharma GmbH
• Thermo Fisher Scientific Inc.
   

Single-use Bioprocessing Probes and Sensors Industry News

• In February 2022, Thermo Fisher Scientific revealed a substantial USD 40 million investment earmarked for enhancing its single-use technology (SUT) manufacturing hub located in Millersburg, Pennsylvania. The primary objective of this expansion endeavor was to fortify the capacity for adaptable, scalable, and reliable bioprocessing production, aimed at meeting the escalating demand for indispensable materials crucial in the advancement of both emerging and established biologics and vaccines. Notably, this investment was strategically tailored to address the exigencies stemming from the COVID-19 pandemic. This expansion positioned the company with a competitive edge in the market.
   

The single-use bioprocessing probes and sensors market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Sensor Type

• pH sensors
• Oxygen sensors
• Pressure sensors
• Temperature sensors
• Conductivity sensors
• Flow meters & sensors
• Other sensor types

Market, By Workflow

• Upstream
• Downstream

Market, By End-use

• Academic and research institutes
• Biopharma & pharmaceutical manufacturers
• CMOs and CDMOs

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe 
• Asia Pacific 
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific 
• Latin America 
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America 
• Middle East and Africa 
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa